LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Phibro Animal Health Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

44.92 -0.35

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

43.91

Max

46.05

Pagrindiniai rodikliai

By Trading Economics

Pajamos

9.3M

27M

Pardavimai

-15M

364M

P/E

Sektoriaus vid.

27.443

105.69

Pelnas, tenkantis vienai akcijai

0.73

Dividendų pajamingumas

1.1

Pelno marža

7.29

Darbuotojai

2,475

EBITDA

11M

51M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

-11.86% downside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.10%

2.37%

Kitas dividendų mokėjimo data

2025-12-17

Kita Ex Dividend data

2025-11-26

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

100M

1.9B

Ankstesnė atidarymo kaina

45.27

Ankstesnė uždarymo kaina

44.92

Naujienos nuotaikos

By Acuity

27%

73%

67 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Phibro Animal Health Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-17 18:59; UTC

Pagrindinės rinkos jėgos

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

2025-11-17 23:40; UTC

Rinkos pokalbiai

Gold Consolidates Amid Mixed Signals -- Market Talk

2025-11-17 23:34; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2025-11-17 22:58; UTC

Rinkos pokalbiai

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

2025-11-17 22:46; UTC

Rinkos pokalbiai

Risk Assets Set to Have a Strong 2026 -- Market Talk

2025-11-17 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

2025-11-17 22:02; UTC

Uždarbis

Trip.com Group 3Q Rev $2.6B >TCOM

2025-11-17 22:02; UTC

Uždarbis

Trip.com Group 3Q Adj EPS $3.87 >TCOM

2025-11-17 22:02; UTC

Uždarbis

Trip.com Group 3Q EPS $4.02 >TCOM

2025-11-17 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-17 21:40; UTC

Uždarbis

James Hardie Industries 2Q Adj EPS 26c >JHX

2025-11-17 21:40; UTC

Uždarbis

James Hardie Industries 2Q Loss/Shr 10c >JHX

2025-11-17 21:39; UTC

Uždarbis

James Hardie Industries 2Q Sales $1.29B >JHX

2025-11-17 21:38; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025-11-17 21:38; UTC

Uždarbis

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

2025-11-17 21:10; UTC

Uždarbis

XP Inc. 3Q EPS BRL2.47 >XP

2025-11-17 21:10; UTC

Uždarbis

XP Inc. 3Q Rev BRL4.67B >XP

2025-11-17 20:20; UTC

Rinkos pokalbiai

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

2025-11-17 20:12; UTC

Rinkos pokalbiai

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

2025-11-17 20:12; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-17 20:09; UTC

Rinkos pokalbiai

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

2025-11-17 19:29; UTC

Rinkos pokalbiai

Gold Slide Continues to Start Week -- Market Talk

2025-11-17 19:16; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025-11-17 18:20; UTC

Įsigijimai, susijungimai, perėmimai

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

2025-11-17 16:45; UTC

Įsigijimai, susijungimai, perėmimai

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

2025-11-17 16:16; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025-11-17 16:15; UTC

Uždarbis

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

2025-11-17 15:40; UTC

Įsigijimai, susijungimai, perėmimai

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

2025-11-17 15:22; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

2025-11-17 15:19; UTC

Rinkos pokalbiai

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Akcijų palyginimas

Kainos pokytis

Phibro Animal Health Corp Prognozė

Kainos tikslas

By TipRanks

-11.86% į apačią

12 mėnesių prognozė

Vidutinis 39.75 USD  -11.86%

Aukščiausias 50 USD

Žemiausias 27 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Phibro Animal Health Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

1

Pirkti

2

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

17 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

67 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat